Xultophy Prices, Coupons and Patient Assistance Programs
Xultophy (insulin degludec/liraglutide) is a member of the antidiabetic combinations drug class and is commonly used for Diabetes - Type 2.
The cost for Xultophy subcutaneous solution (100 units-3.6 mg/mL) is around $1,205 for a supply of 15 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Xultophy price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
|15 (5 x 3 milliliters)||$80.35||$1,205.26|
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Xultophy Coupons and Rebates
Xultophy offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
There are currently no Manufacturer Promotions that we know about for this drug.
Patient Assistance Programs for Xultophy
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: NovoCare Patient Support ProgramsElligibility requirements:
- Determined case by case
- Determined case by case
- FDA-approved diagnosis
- The patient must also be a US resident.
- Co-payment assistance and patient assistance programs are available for eligible patients. Contact program for details: Diabetes: 844-668-6463 (844-Novo4Me) Obesity: 888-809-3942 Growth Hormone: 888-668-6444 Hemophilia: 844-668-6732
- Xultophy (insulin degludec/liraglutide) Injection; Subcutaneous
More information please phone: 888-668-6444 or 844-668-6463 Visit Website
Provider: Novo Nordisk Patient Assistance ProgramElligibility requirements:
- Must be uninsured
- At or below 400% of FPL
- Not specified
- The patient must be a US citizen or legal resident.
- This program also provides copay assistance. *Medicare Part D enrollment deadline is November 30 of each year.
- Xultophy 100-3.6 (insulin degludec/liraglutide) Pen
More information please phone: 866-310-7549 or 844-668-6463 Visit Website
More about Xultophy (insulin degludec / liraglutide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 3 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (1)
- FDA Approval History